|
Children's Oncology Group Chair's Grant
|
5U10CA098543-08
|
$26,966,030
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Participation in the Eastern Cooperative Oncology Group
|
2U10CA107868-07
|
$235,766
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
ATBC Study
|
ZIA CP010195 03031
|
$853,810
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Vitamin D Pooling Project
|
ZIA CP010195 10436
|
$337,546
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S1
|
$100,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S2
|
$143,893
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S3
|
$100,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-32
|
$4,161,905
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$771,635
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S1
|
$1,499,003
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S2
|
$39,636
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S3
|
$39,636
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-08
|
$5,935,261
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Identifying a Hypoxia Inducible Factor target profile in Renal Cell Carcinoma tum
|
1F31CA154080-01
|
$33,695
|
Arreola, Alexandra
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-12
|
$104,956
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-07
|
$2,300,000
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
5R01CA077091-07
|
$352,225
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
|
5R44CA121612-03
|
$685,832
|
Aung, Sandra
|
UBIVAC, LLC
|
|
Eastern Cooperative Oncology Group Studies
|
2U10CA014548-36
|
$420,754
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-20
|
$252,182
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Southwest Oncology Group Treatment Grant
|
2U10CA032102-31
|
$10,205,783
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-31S2
|
$1,500,000
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The 50th Annual Meeting of the American Society of Pharmacognosy
|
5R13CA139768-02
|
$2,500
|
BAKER, BILL
|
UNIVERSITY OF SOUTH FLORIDA
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-26
|
$11,261,801
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-13
|
$360,039
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$103,901
|
Bates, Susan
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$363,655
|
Bates, Susan
|
CCR (NCI)
|
|
The Gulf Coast MBCCOP
|
5U10CA128536-04
|
$499,869
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Iowa Oncology Research Association
|
5U10CA035101-25
|
$685,544
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
ECOG Clinical Trials
|
2U10CA017145-35
|
$455,484
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S1
|
$124,531
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S2
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S3
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S4
|
$46,458
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
2U10CA063844-17
|
$837,264
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
3U10CA063844-17S1
|
$100,000
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Eastern Cooperative Oncology Group
|
2U10CA049957-22
|
$367,534
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-27
|
$428,852
|
Bernath, Albert
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
Cancer and Leukemia Group B
|
3U10CA031946-29S3
|
$8,129,333
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
7U10CA031946-29
|
$11,034,745
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mechanism of Acquired Resistance to VEGF-R Antagonists in RCC
|
1K08CA138900-01A1
|
$169,560
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-19
|
$266,860
|
BIEGEL, JACLYN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
1U10CA142559-01
|
$188,304
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Mechanisms of Renal Carcinogenesis
|
5R01CA131272-03
|
$226,091
|
Block, Karen
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Cancer and Leukemia Group B - The Ohio State University
|
7U10CA077658-13
|
$503,136
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$73,390
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$220,169
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$440,337
|
Bottaro, Donald
|
CCR (NCI)
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
5R01CA054498-19
|
$1,041,309
|
BRESLOW, NORMAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|